Olmy-AH Tablet
Images are for reference. Actual packaging may vary.
Olmesartan Medoxomil (20mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+2 more active ingredients
Olmesartan Medoxomil blocks angiotensin II receptors, preventing vasoconstriction and lowering blood pressure.
Hydrochlorothiazide inhibits sodium reabsorption in the distal convoluted tubule, leading to increased urine output and decreased blood volume.
Amlodipine inhibits calcium ion influx into vascular smooth muscle and cardiac muscle, leading to vasodilation and reduced myocardial oxygen demand.
Medical applications
Olmy-AH Tablet is a fixed-dose combination medication containing Olmesartan Medoxomil 20 mg, Amlodipine 5 mg, and Hydrochlorothiazide 12.5 mg, indicated for the management of hypertension. Olmesartan Medoxomil, an angiotensin II receptor blocker (ARB), functions by inhibiting the vasoconstrictive effects of angiotensin II, thereby reducing peripheral vascular resistance and lowering blood pressure.
Amlodipine, a dihydropyridine calcium channel blocker, promotes vasodilation by inhibiting calcium influx into vascular smooth muscle cells, further contributing to blood pressure reduction. Hydrochlorothiazide, a thiazide diuretic, facilitates the excretion of sodium and water by acting on the distal convoluted tubules of the kidneys, decreasing plasma volume and systemic vascular resistance.
The combination of these three agents offers complementary mechanisms of action, providing enhanced antihypertensive efficacy compared to monotherapy. Olmy-AH is indicated for patients whose blood pressure is not adequately controlled with monotherapy or dual therapy. It is essential to monitor renal function, electrolytes, and blood pressure regularly during treatment. Caution is advised in patients with renal or hepatic impairment, electrolyte imbalance, or hypersensitivity to any component.
Olmy-AH should be used under medical supervision, with adherence to prescribed dosage to optimize therapeutic outcomes and minimize adverse effects.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Olmy-AH Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Olmy-AH Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Olmy-AH Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Olmy-AH Tablet may be needed. Please consult your doctor. Use of Olmy-AH Tablet is not recommended in patients with severe kidney disease.
Exercise Caution
Olmy-AH Tablet may cause side effects which could affect your ability to drive. Olmy-AH Tablet may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.
Consult Doctor
Olmy-AH Tablet should be used with caution in patients with liver disease. Dose adjustment of Olmy-AH Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Olmy-AH Tablet






